论文部分内容阅读
慢性粒细胞白血病(CML)慢性期目前采用羟基脲联合α-干扰素治疗,单用羟基脲对部分并巨脾患者效果差,我科1998年以来用EA方案治疗8例经羟基脲或马利兰治疗无效的CML并巨脾患者,取得较理想的近期疗效,现报告如下。1 资料与方法1.1 一般资料 8例CML均经临床、血象及骨髓象确诊,
Chronic myeloid leukemia (CML) is currently treated with hydroxyurea combined with α-interferon, with hydroxyurea on some patients with splenomegaly and poor results, our department since 1998 with EA regimen in 8 cases treated with hydroxyurea or Maryland Invalid CML and splenomegaly patients, to achieve better immediate effect, are as follows. 1 Materials and Methods 1.1 General Information 8 cases of CML by clinical, blood and bone marrow as confirmed,